New combo therapy aims to keep ovarian cancer at bay longer
NCT ID NCT05009082
First seen Jun 25, 2026 · Last updated Jun 26, 2026 · Updated 1 time
Summary
This Phase 3 trial is testing whether adding bevacizumab to niraparib after standard chemotherapy helps women with newly diagnosed advanced ovarian cancer stay cancer-free longer. About 970 participants will receive either niraparib alone or niraparib plus bevacizumab as maintenance therapy. The study compares how long the cancer stays under control and monitors side effects.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Niraparib and bevacizumab
- What this could lead to
- If successful, this combination could extend the time women with advanced ovarian cancer live without their disease worsening, offering a new standard treatment option.
- What could go wrong
- This is a large Phase 3 trial, but results may not apply to all ovarian cancer types. Adding bevacizumab also increases side effects like high blood pressure and bleeding risk.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADVANCED HIGH GRADE NON-MUCINOUS NON-CLEAR CELL EPITHELIAL OVARIAN CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Albertinen Krankenhaus
RECRUITINGHamburg, Germany
-
Florence-Nightingale-Krankenhaus Düsseldorf
NOT_YET_RECRUITINGDüsseldorf, Germany
-
Gyn.-onkolog. Gemeinschaftspraxis Hildesheim
RECRUITINGHildesheim, Germany
-
Gynäkologisch-Onkologische Praxis am Pelikanplatz
RECRUITINGHanover, Germany
-
Helios Klinikum Berlin-Buch
RECRUITINGBerlin, Germany
-
Hochtaunus-Kliniken
RECRUITINGBad Homburg, Germany
-
KEM Essen | Evang. Kliniken Essen-Mitte gGmbH
RECRUITINGEssen, Germany
-
Klinikum Augsburg
RECRUITINGAugsburg, Germany
-
Klinikum Bremen Mitte
RECRUITINGBremen, Germany
-
Klinikum Chemnitz
RECRUITINGChemnitz, Germany
-
Klinikum Dortmund
RECRUITINGDortmund, Germany
-
Klinikum Esslingen GmbH
RECRUITINGEsslingen am Neckar, Germany
-
Klinikum Frankfurt Höchst
RECRUITINGFrankfurt am Main, Germany
-
Klinikum Gütersloh
RECRUITINGGütersloh, Germany
-
Klinikum Kassel
RECRUITINGKassel, Germany
-
Klinikum Konstanz
NOT_YET_RECRUITINGKonstanz, Germany
-
Klinikum Ludwigsburg
RECRUITINGLudwigsburg, Germany
-
Klinikum Mutterhaus
RECRUITINGTrier, Germany
-
Klinikum Neumarkt
RECRUITINGNeumarkt, Germany
-
Klinikum St. Marien Amberg
RECRUITINGAmberg, Germany
-
Klinikum Stuttgart
RECRUITINGStuttgart, Germany
-
Klinikum Südstadt Rostock
RECRUITINGRostock, Germany
-
Klinikum Traunstein
RECRUITINGTraunstein, Germany
-
Klinikum Worms
RECRUITINGWorms, Germany
-
Klinikum am Gesundbrunnen / SLK-Kliniken Heilbronn GmbH
RECRUITINGHeilbronn, Germany
-
Klinikum am Steinenberg
RECRUITINGReutlingen, Germany
-
Klinikverbund Kempten-Oberallgäu gGmbH
NOT_YET_RECRUITINGKempten, Germany
-
Krankenhaus Barmherzige Brüder
RECRUITINGRegensburg, Germany
-
LMU Klinikum München-Großhadern
RECRUITINGMünchen, Germany
-
Leopoldina Krankenhaus Schweinfurt
RECRUITINGSchweinfurt, Germany
-
MVZ Nordhausen
RECRUITINGNordhausen, Germany
-
Mammazentrum HH am Krankenhaus Jerusalem
RECRUITINGHamburg, Germany
-
Mühlenkreiskliniken, Johannes Wesling Klinikum Minden
RECRUITINGMinden, Germany
-
Onkologische Schwerpunktpraxis Bielefeld
RECRUITINGBielefeld, Germany
-
Ortenau Klinikum Offenburg-Kehl
RECRUITINGOffenburg, Germany
-
RoMed Klinikum Rosenheim
RECRUITINGRosenheim, Germany
-
Rotkreuzklinikum München
RECRUITINGMünchen, Germany
-
St. Elisabeth-Krankenhaus Köln-Hohenlind
RECRUITINGCologne, Germany
-
St. Josefs-Hospital
RECRUITINGWiesbaden, Germany
-
St. Vincenz Krankenhaus
RECRUITINGLimburg, Germany
-
St. Vincenz Krankenhaus GmbH
RECRUITINGPaderborn, Germany
-
Studienzentrum Onkologie Ravensburg
RECRUITINGRavensburg, Germany
-
Städt. Klinikum Brandenburg
RECRUITINGBrandenburg an der Havel, Germany
-
Städtisches Klinikum Karlsruhe
RECRUITINGKarlsruhe, Germany
-
Thüringen-Kliniken "Georgius Agricola"
RECRUITINGSaalfeld, Germany
-
UKGM Gießen/Marburg Standort Marburg
RECRUITINGMarburg, Germany
-
UKSH Campus Lübeck
RECRUITINGLübeck, Germany
-
Universitätsfrauenklinik Düsseldorf
RECRUITINGDüsseldorf, Germany
-
Universitätsklinik Ulm
RECRUITINGUlm, Germany
-
Universitätsklinikum Carl Gustav Carus Dresden
RECRUITINGDresden, Germany
-
Universitätsklinikum Essen
RECRUITINGEssen, Germany
-
Universitätsklinikum Frankfurt
RECRUITINGFrankfurt, Germany
-
Universitätsklinikum Gießen
RECRUITINGGiessen, Germany
-
Universitätsklinikum Halle
RECRUITINGHalle, Germany
-
Universitätsklinikum Hamburg-Eppendorf
RECRUITINGHamburg, Germany
-
Universitätsklinikum Leipzig
RECRUITINGLeipzig, Germany
-
Universitätsklinikum Mannheim GmbH
RECRUITINGMannheim, Germany
-
Universitätsklinikum Münster
RECRUITINGMünster, Germany
-
Universitätsklinikum Tübingen
RECRUITINGTübingen, Germany
-
Universitätsklnikum Heidelberg
RECRUITINGHeidelberg, Germany
-
Universitätsmedizin Mainz
RECRUITINGMainz, Germany
-
Universtitätsklinikum Jena
RECRUITINGJena, Germany
-
ViDia Christliche Kliniken Karlsruhe
RECRUITINGKarlsruhe, Germany
-
Zentrum für ambulante gynäkologische Onkologie am HELIOS Klinikum Krefeld
RECRUITINGKrefeld, Germany
-
g.SUND
RECRUITINGStralsund, Germany
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a new drug combo revive Immunotherapy's power against resistant tumors?
- Can a new PET tracer light up hidden cancers?
- A Two-for-One surgery: could tube removal during Weight-Loss surgery slash ovarian cancer risk?
- Can AI spot ovarian cancer on CT scans before It's too late?
- Can Lab-Grown tumors unlock the secrets of ovarian cancer resistance?
- Can a smart drug home in on Hard-to-Treat cancers?